11. Preliminary results of laparoscopic complete mesocolic excision for colon cancer treatment

Nguyen Minh Thao, Dao Thi Minh Ha, Giap Bach Kim Tuyen, Pham Anh Vu

Main Article Content

Abstract

Laparoscopic complete mesocolic excision (CME) has more lymph nodes resected than traditional laparoscopic colectomy. The laparoscopic CME has not been extensively described as a safe strategy. The current study aims to evaluate clinical characteristics and preliminary results of laparoscopic CME in colon cancer. This is a descriptive study of 30 patients at the Hue University of Medicine and Pharmacy Hospital and Hue Central Hospital from May 2021 to July 2022. The mean age was 63.9 ± 15.0, and males accounted for 53.3%. ASA 1 was the majority, with a rate of 60.0%. 53.3% of patients had moderate and high nutritional risk. The sigmoid colon tumors were highest at 40.0%. The prevalence of splenic flexure colon, the same transverse colon location, was a minor proportion at 3.3%. The sigmoidectomy and sigmoidectomy and partial of upper third rectal resection accounted for 40.0%. The mean (range) of the length of hospital stay was 7.0 ± 1.5 days. The specimen length, mesentery width, and lymph nodes average were 30.9 ± 8.0cm, 9.2 ± 1.7cm, and 59.1 ± 19.7, respectively. The average tumor size was 4.4 ± 1.9cm. The analytical plane achieved 83.3% of the complete mesenteric plane. AJCC 8th Stage I after surgery accounted for 40.0%, followed by stages IIIb, and IIa with 36.7% and 13.3%, respectively. Only three patients had complications of surgical site infection, accounting for 10.0%, and one with abdominal subcutaneous emphysema and urinary retention accounted for 3.3%. From the preliminary results, we suggest that laparoscopic CME colectomy is feasible, safe, and reliable with maximal lymph node retrieval.

Article Details

References

1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3): 209-249. doi: 10.3322/caac.21660.
2. Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020; 70(3): 145-164. doi: 10.3322/caac.21601.
3. Tran Le N, Viet Dao H. Colorectal Cancer in Vietnam. IntechOpen. 2020; 418:1-21. doi: 10.5772/intechopen.93730.
4. Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: Complete mesocolic excision and central ligation - Technical notes and outcome. Colorectal Disease. 2009; 11(4): 354-364. doi: 10.1111/j.1463-1318.2008.01735.x.
5. Bertelsen CA, Neuenschwander AU, Jansen JE, et al. 5-Year Outcome After Complete Mesocolic Excision for Right-Sided Colon Cancer: a Population-Based Cohort Study. Lancet Oncol. 2019; 20(11): 1556-1565. doi: 10.1016/S1470-2045(19)30485-1.
6. Galizia G, Lieto E, de Vita F, et al. Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers? A prospective study. Int J Colorectal Dis. 2014; 29(1): 89-97. doi: 10.1007/s00384-013-1766-x.
7. Madoff RD. Defining quality in colon cancer surgery. Journal of Clinical Oncology. 2012; 30(15): 1738-1740. doi: 10.1200/JCO.2011.40.9615.
8. Nursal TZ, Noyan T, Tarim A, Karakayali H. A new weighted scoring system for Subjective Global Assessment. Nutrition. 2005; 21(6): 666-671. doi: 10.1016/j.nut.2004.08.027.
9. Cho MS, Baek SJ, Hur H, Min BS, Baik SH, Kim NK. Modified complete mesocolic excision with central vascular ligation for the treatment of right-sided colon cancer: Long-term outcomes and prognostic factors. Ann Surg. 2015; 261(4): 708-715. doi: 10.1097/SLA.0000000000000831.
10. Hashiguchi Y, Muro K, Saito Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2019 for the Treatment of Colorectal Cancer. Vol 25. Springer Singapore; 2020. doi: 10.1007/s10147-019-01485-z.
11. Huang JL, Wei HB, Fang J feng, et al. Comparison of laparoscopic versus open complete mesocolic excision for right colon cancer. International Journal of Surgery. 2015; 23: 12-17. doi: 10.1016/j.ijsu.2015.08.037.
12. Park JH, Kim DH, Kim BR, Kim YW. The American Society of Anesthesiologists score influences on postoperative complications and total hospital charges after laparoscopic colorectal cancer surgery. Medicine (United States). 2018; 97(18). doi: 10.1097/MD.0000000000010653.
13. Weimann A, Braga M, Carli F, et al. ESPEN practical guideline: Clinical nutrition in surgery. Clinical Nutrition. 2021; 40(7): 4745-4761. doi: 10.1016/j.clnu.2021.03.031.
14. Shen SS, Haupt BX, Ro JY, Zhu J, Bailey HR, Schwartz MR. Number of lymph nodes examined and associated clinicopathologic factors in colorectal carcinoma. Arch Pathol Lab Med. 2009; 133(5): 781-786. doi: 10.5858/133.5.781.
15. Horne J, Bateman AC, Carr NJ, Ryder I. Lymph node revealing solutions in colorectal cancer: Should they be used routinely? J Clin Pathol. 2014; 67(5): 383-388. doi: 10.1136/jclinpath-2013-202146.
16. Schumacher P, Dineen S, Barnett C, Fleming J, Anthony T. The metastatic lymph node ratio predicts survival in colon cancer. Am J Surg. 2007; 194(6): 827-832. doi: 10.1016/j.amjsurg.2007.08.030.